DEF: Sotera Health Sets May 21, 2026 Annual Meeting Date
Proxy Statement
Sotera Health Company has announced its 2026 Annual Meeting of Stockholders, scheduled for May 21, 2026, to elect directors, approve executive compensation, and ratify auditor appointment.
Summary
- Sotera Health Company is holding its Annual Meeting of Stockholders on Thursday, May 21, 2026, at 9:00 a.m. Eastern Daylight Time.
- The meeting will be conducted virtually via a live audio webcast at www.virtualshareholdermeeting.com/SHC2026.
- Stockholders of record as of Friday, March 27, 2026, are eligible to vote.
- Key proposals include the election of four Class III directors, an advisory vote on executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026.
- The Board of Directors recommends voting FOR all proposed director nominees and proposals.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it pertains to routine corporate governance matters and does not contain new financial performance data or strategic shifts.
Positives
- The company is holding its annual meeting to ensure shareholder engagement and governance.
- The board has recommended approval for all key proposals, indicating confidence in current management and strategy.
- The company is providing clear instructions for virtual attendance and voting, facilitating shareholder participation.
Future Outlook
The filing primarily concerns the upcoming annual meeting and does not contain specific forward-looking financial guidance.
Management Comments
- The Board recommends you vote (1) FOR the election of the four nominees for directors named in this Proxy Statement, (2) FOR the approval, on an advisory basis, of the compensation of our named executive officers and (3) FOR the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Your vote is important to us.
Industry Context
StockSavvy.ai notes that the scheduling of annual meetings and the election of directors are standard corporate governance practices across the healthcare and life sciences industries, reflecting a commitment to shareholder oversight.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class III Director | Sean L. Cunningham | Nomination for election | ||
| Class III Director | Richard G. Kyle | Nomination for election | ||
| Class III Director | Vincent K. Petrella | Nomination for election | ||
| Class III Director | Christopher A. Simon | Nomination for election | ||
| Class I Director | Constantine S. Mihas | Kenneth D. Krause | 2026-03-16 | Resignation and appointment to fill vacancy |
| Class III Director | Robert B. Knauss | 2026-05-21 | Not standing for re-election |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Size Reduction | Following the Annual Meeting, the Board expects to reduce its size from twelve directors to eleven directors. | 2026-05-21 | Minor structural change to the board composition. |
Related Party Transactions
- Sales of approximately $1.0 million to Curia Global, an affiliate of Warburg Pincus.
- Payments of approximately $0.4 million to Quantum Health, an affiliate of Warburg Pincus.
- Payments of approximately $0.4 million to City Wide Facility Solutions, an affiliate of Warburg Pincus.
- Payments of approximately $125,000 to PPC Flex, LLC, an affiliate of Warburg Pincus.
Stakeholder Impact
- Shareholders will have the opportunity to vote on director elections and executive compensation, influencing corporate governance.
- The ratification of the auditor appointment ensures continued independent financial oversight.
Next Steps
- Stockholders to vote on the proposed director nominees.
- Stockholders to provide an advisory vote on the compensation of named executive officers.
- Stockholders to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm.
- Company to hold the Annual Meeting of Stockholders virtually on May 21, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-03-27 | Record Date for determining stockholders entitled to vote at the Annual Meeting. |
| 2026-05-20 | Deadline for voting via internet or telephone. |
| 2026-05-21 | Date of the Annual Meeting of Stockholders. |
Keywords
Sotera Health, Annual Meeting, Proxy Statement, Director Election, Executive Compensation, Independent Auditor, Stockholder Vote
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.